Mumbai based Aanjaneya Lifecare Ltd is India’s leading research based health management company with established research, manufacturing & marketing capabilities. Drug maker company is planning to enter capital markets with its maiden public issue of 50 lakh equity shares of face value Rs 10 each. The company has filed a Draft Red Herring Prospectus (DRHP) on 14th Sep 2010 with market regulator Securities and Exchange Board of India (SEBI). The premium to be decided via 100% book building process. The issue constitutes 39.76% of the fully diluted post-issue paid up capital of the company.
Currently promoters Aasda Life Care Limited and Dr Kannan K Vishwanath hold 73.25% and 26.75% stake in the company, which will be reduced to 60.24% (in total) post issue. The company is also considering a pre-IPO placement of up to Rs 30 crore with certain investors and may consider participation by anchor investors.
The proceeds of the issue would be deployed for setting up different plants, to expand existing R&D, to meet the expenses for branding and registration of products in the international markets, among others with expansion plans of about Rs 100 crore.
The Equity Shares are proposed to be listed on the Bombay Stock Exchange Limited (BSE) and the National Stock Exchange of India Limited (NSE).
The Book running lead managers to the issue are Anand Rathi Advisors and IDBI Capital Market Services.
Registrar of the Issue : Link Intime (India).
Stay tuned to BelltheBull Blog for more on Aanjaneya Lifecare IPO !Google+